Swiss National Bank’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-108,900
| Closed | -$114K | – | 2506 |
|
|
2023
Q4 | $114K | Hold |
108,900
| – | – | ﹤0.01% | 2533 |
|
|
2023
Q3 | $746K | Hold |
108,900
| – | – | ﹤0.01% | 2391 |
|
|
2023
Q2 | $1.13M | Buy |
108,900
+8,100
| +8% | +$84K | ﹤0.01% | 2225 |
|
|
2023
Q1 | $815K | Sell |
100,800
-11,800
| -10% | -$95.5K | ﹤0.01% | 2364 |
|
|
2022
Q4 | $1.77M | Buy |
112,600
+2,100
| +2% | +$33.1K | ﹤0.01% | 1963 |
|
|
2022
Q3 | $1.74M | Buy |
110,500
+9,500
| +9% | +$150K | ﹤0.01% | 1966 |
|
|
2022
Q2 | $1.41M | Sell |
101,000
-7,500
| -7% | -$105K | ﹤0.01% | 2157 |
|
|
2022
Q1 | $1.87M | Buy |
108,500
+7,500
| +7% | +$129K | ﹤0.01% | 2074 |
|
|
2021
Q4 | $1.47M | Buy |
101,000
+3,800
| +4% | +$55.3K | ﹤0.01% | 2243 |
|
|
2021
Q3 | $1.75M | Hold |
97,200
| – | – | ﹤0.01% | 2139 |
|
|
2021
Q2 | $1.71M | Buy |
+97,200
| New | +$1.71M | ﹤0.01% | 2211 |
|
|
2019
Q2 | – | Sell |
-63,400
| Closed | -$380K | – | 2555 |
|
|
2019
Q1 | $380K | Buy |
63,400
+5,400
| +9% | +$32.4K | ﹤0.01% | 2427 |
|
|
2018
Q4 | $429K | Buy |
58,000
+16,100
| +38% | +$119K | ﹤0.01% | 2403 |
|
|
2018
Q3 | $608K | Hold |
41,900
| – | – | ﹤0.01% | 2361 |
|
|
2018
Q2 | $837K | Hold |
41,900
| – | – | ﹤0.01% | 2267 |
|
|
2018
Q1 | $734K | Buy |
41,900
+2,600
| +7% | +$45.5K | ﹤0.01% | 2256 |
|
|
2017
Q4 | $969K | Hold |
39,300
| – | – | ﹤0.01% | 2112 |
|
|
2017
Q3 | $1.01M | Buy |
39,300
+10,000
| +34% | +$258K | ﹤0.01% | 2059 |
|
|
2017
Q2 | $795K | Hold |
29,300
| – | – | ﹤0.01% | 2189 |
|
|
2017
Q1 | $874K | Hold |
29,300
| – | – | ﹤0.01% | 2111 |
|
|
2016
Q4 | $795K | Buy |
29,300
+14,000
| +92% | +$380K | ﹤0.01% | 2176 |
|
|
2016
Q3 | $392K | Hold |
15,300
| – | – | ﹤0.01% | 2423 |
|
|
2016
Q2 | $283K | Buy |
+15,300
| New | +$283K | ﹤0.01% | 2523 |
|